University of Texas MD Anderson Cancer Center

Our News on Newswise
View All >

NK Cells Complexed with Bispecific Antibody Yield High Response Rates in Patients with Lymphoma

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates for patients with refractory CD30-positive...
3-Apr-2025 8:20 PM EDT Add to Favorites

Newswise: 67ead168bbdb1_FinalGroundbreaking.jpg

MD Anderson Breaks Ground on New Sugar Land Location

The University of Texas MD Anderson Cancer Center today broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services and MD Anderson鈥檚 unparalleled patient experience closer to those living in Southwest...
31-Mar-2025 7:10 PM EDT Add to Favorites

Newswise: 67e61a4411a67_henrykuerer.jpg.resize.810.1150.high.jpg

Surgery May Not Be Necessary to Treat Invasive Breast Cancer

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment, according to new data from researchers at The...
28-Mar-2025 5:45 AM EDT Add to Favorites

MD Anderson Research Highlights for March 27, 2025

The University of Texas MD Anderson Cancer Center鈥檚 Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson鈥檚...
27-Mar-2025 6:10 PM EDT Add to Favorites

Newswise: 67e4c67d5de08_PR2025-5322AAASAwardPR.jpg

Two MD Anderson Researchers Elected AAAS Fellows

In recognition of their significant achievements to advance cancer care and research, Lauren Byers, M.D., and Paul Scheet, Ph.D., from The University of Texas MD鈥疉nderson Cancer Center have been elected fellows of the American Association for the...
27-Mar-2025 5:20 AM EDT Add to Favorites

MD Anderson names Jeffrey E. Lee, M.D., Chief Medical Executive

The University of Texas MD Anderson Cancer Center today announced that Jeffrey E. Lee, M.D., an internationally regarded leader in the field of oncology, has been appointed chief medical executive (CME) effective April 1.
26-Mar-2025 9:05 PM EDT Add to Favorites

MD Anderson Research Highlights for March 12, 2025

F. W. Bert and Mae Dean Wheeler Foundation Establishes Nurse Leadership Academy at MD Anderson with $9 Million Gift

The University of Texas MD Anderson Cancer Center today announced a $9 million gift from the F. W. Bert and Mae Dean Wheeler Foundation to establish the F. W. Bert and Mae Dean Wheeler Nurse Leadership Academy.
5-Mar-2025 8:25 AM EST Add to Favorites

See All News

Our Experts on Newswise

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country鈥檚 health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

AUDIO

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

AUDIO

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

See All Experts

Our YouTube Videos
View All >

About

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution鈥檚 sole mission is to end cancer for patients and their families around the world, and, in 1971, it became one of the nation鈥檚 first National Cancer Institute (NCI)-designated comprehensive cancer centers. MD Anderson is No. 1 for cancer in U.S. News & World Report鈥檚鈥淏est Hospitals鈥� rankings and has been named one of the nation鈥檚 top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).